Blood test shows promise for detecting pancreatic cancer at its earliest stages

Researchers at City of Hope have developed a new investigational blood test capable of detecting pancreatic cancer at its earliest stages, when the disease is most treatable and potentially curable. Early detection is critical for pancreatic cancer, as the disease is often diagnosed at advanced stages when treatment options are limited. This breakthrough could significantly improve survival rates and patient outcomes by enabling intervention before the cancer spreads. The advancement represents an important step toward making pancreatic cancer screening more accessible and effective for at-risk populations.